BMD Result Letter and Brochure vs Control: deaths from any cause
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
Measures 6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note | Source |
|---|---|---|---|---|---|---|
| Risk in group 1 | 0.00667 | 0.00456 | 0.00976 | wilson | ClinicalTrials.gov | |
| Risk in group 2 | 0.00467 | 0.00296 | 0.00738 | wilson | ClinicalTrials.gov | |
| Risk difference, group 1 minus group 2 | 0.002 | -0.00144 | 0.00553 | newcombe hybrid score | ClinicalTrials.gov | |
| Risk ratio, group 1 over group 2 | 1.43 | 0.784 | 2.6 | log | ClinicalTrials.gov | |
| Odds ratio, group 1 over group 2 | 1.43 | 0.783 | 2.61 | log | ClinicalTrials.gov | |
| Number needed to harm, for one more death from any cause on BMD Result Letter and Brochure than on Control | 501 | from the risk difference interval | the interval includes no difference | ClinicalTrials.gov |
Groups 2
Group 2 names the comparator: control.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code | Source |
|---|---|---|---|---|---|---|
| Group 1 | BMD Result Letter and Brochure | Patients who receive the intervention - BMD result letter with brochure~Bone Mineral Density Result Letter and Bone Health Brochure: Letter mailed to patient to include - Date of DXA, T-score, impression, 10 year major fracture risk with visual depiction of risk, basic bone health guidelines, instructions to follow-up with their healthcare provider. The brochure will include information on osteoporosis, calcium, vitamin D, medicines, exercise, tobacco and alcohol cessation and where to find more information. | 26 | 3,898 | EG000 | ClinicalTrials.gov |
| Group 2 | Control | Usual care | 18 | 3,851 | EG001 | ClinicalTrials.gov |
Harm 2
| Field | Value | Source |
|---|---|---|
| What it counts | Total, all-cause mortality | ClinicalTrials.gov |
| Time frame | ClinicalTrials.gov |
Trial 8
| Field | Value | Source |
|---|---|---|
| Title | Patient Activation After DXA Result Notification | ClinicalTrials.gov |
| NCT number | NCT01507662 | ClinicalTrials.gov |
| Phases | NA | ClinicalTrials.gov |
| Conditions | Osteoporosis, Bone Diseases, Metabolic | ClinicalTrials.gov |
| Interventions | Bone Mineral Density Result Letter and Bone Health Brochure | ClinicalTrials.gov |
| Lead sponsor | Fredric D Wolinsky | ClinicalTrials.gov |
| Results first posted | 2017-04-11 | ClinicalTrials.gov |
| Results on ClinicalTrials.gov | https://clinicaltrials.gov/study/NCT01507662?tab=results | ClinicalTrials.gov |
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trial-comparisons-2026-03-23-0.1.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57 | ClinicalTrials.gov |
| AACT copy | 2026-03-23 | ClinicalTrials.gov |
| Tables read | outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet | ClinicalTrials.gov |
Release trial-comparisons-2026-03-23-0.1.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.